Autologous DCs were transduced with vaccine: an adenovirus encoding a truncated LMP1 and full length LMP2 (Ad-ΔLMP1-LMP2). In a phase II trial, vaccine transduced DCs could be generated and safely administered to NPC patients with extensive disease. No significant toxicity was observed. This evidence concerns the gene PSMB9 and nasopharyngeal carcinoma.